ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,298,000 | -20.8% | 94,275 | -47.0% | 0.56% | +16.8% |
| Q1 2018 | $2,901,000 | +38.3% | 177,747 | +8.5% | 0.48% | +28.5% |
| Q4 2017 | $2,097,000 | -15.7% | 163,818 | -19.0% | 0.38% | +13.6% |
| Q3 2017 | $2,488,000 | +321.7% | 202,309 | +201.2% | 0.33% | +324.4% |
| Q4 2016 | $590,000 | -40.0% | 67,178 | -53.9% | 0.08% | -40.9% |
| Q3 2016 | $983,000 | -10.6% | 145,682 | -2.3% | 0.13% | +3.9% |
| Q1 2015 | $1,099,000 | – | 149,121 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |